Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001213900-22-008513
Filing Date
2022-02-18
Accepted
2022-02-18 17:30:20
Documents
1
Group Members
RONALD HAFNER

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G ea155940-13gmagnetic_nlsphar.htm SC 13G 67138
  Complete submission text file 0001213900-22-008513.txt   68678
Mailing Address THE CIRCLE 6 8058 ZURICH V8 CH-6370
Business Address THE CIRCLE 6 8058 ZURICH V8 CH-6370 41-41-618-80-00
NLS Pharmaceutics Ltd. (Subject) CIK: 0001783036 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92065 | Film No.: 22654047
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NLS PHARMACEUTICS LTD. THE CIRCLE 6 ZURICH V8 8058
Business Address C/O NLS PHARMACEUTICS LTD. THE CIRCLE 6 ZURICH V8 8058 41.44.512.2150
Magnetic Rock Investment AG (Filed by) CIK: 0001912336 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13G